Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC

Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC

Intravesical Bacille Calmette-Guérin (BCG) remains the most effective treatment for high-risk non-muscle-invasive bladder cancer (NMIBC), unfortunately there is no validated biomarker to predict clinical outcome. Here we tried to explore the possibility that a combination of the density of peritumor...

Full description

Bibliographic Details
Main Authors: Roberto Martínez, Gustavo Tapia, Silvia De Muga, Alba Hernández, Maria González Cao, Cristina Teixidó, Victor Urrea, Elisabet García, Sònia Pedreño-López, Luis Ibarz, Julià Blanco, Bonaventura Clotet, Cecilia Cabrera
Format: Article
Language:English
Published: Taylor & Francis Group 2019-08-01
Series:OncoImmunology
Subjects:
nmibc
bcg immunotherapy
gata-3
t-bet
nlr
biomarker
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1602460

Internet

http://dx.doi.org/10.1080/2162402X.2019.1602460

Similar Items